-
Mashup Score: 0
Read the full article here
Tweet
-
Mashup Score: 31Discordance and Performance of the ARC-HBR and PRECISE-DAPT High Bleeding Risk Definitions After Coronary Stenting: - 2 day(s) ago
Read the full article here
Tweet-
📊💉 New #JACCINT study on high bleeding risk after coronary stenting! ARC-HBR & PRECISE-DAPT tools show discordance in identifying patients at risk. Both scores linked to higher bleeding & ischemic events. ⚖️🔍 Need for better scoring! 🫀 https://t.co/oQemrU9cvi #DAPT https://t.co/WMI1rwq2e4
-
-
Mashup Score: 107Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCT - 2 day(s) ago
Read the full article here
Tweet-
#CRT2025 #JACCINT BIOADAPTOR RCT: Significant sustained clinical benefit at 2 years with DynamX #bioadaptor over a contemporary drug-eluting stent in patients with de novo lesions https://t.co/v3PEeudOeZ #cvCAD https://t.co/Br6KJUaNn4
-
-
Mashup Score: 52Rotational Atherectomy, Lithotripsy, or Laser for Calcified Coronary Stenosis: The ROLLER COASTR-EPIC22 Trial - 2 day(s) ago
Read the full article here
Tweet-
🚨 NEW STUDY ALERT 🚨 ROLLER COASTR-EPIC22 trial compares 3 treatments for calcified coronary lesions: RA, IVL, & ELCA 🏥✨ IVL shows noninferiority to RA in stent expansion, while ELCA falls short 🚑 Low complications overall https://t.co/O2HEPBi91b #JACCINT #PCI #atherectomy https://t.co/O4TtRUjEB0
-
-
Mashup Score: 84A Revised Optical Coherence Tomography–Derived Calcium Score to Predict Stent Underexpansion in Severely Calcified Lesions: - 2 day(s) ago
Read the full article here
Tweet-
🔬 New in #JACCINT! A revised #OCT-derived calcium score predicts stent underexpansion in severely calcified lesions 🫀💡. This reliable tool helps identify at-risk lesions, improving stent deployment outcomes 📊 Read more 👉 https://t.co/e9bl3VGJFf https://t.co/dEq8O3VVVF
-
-
Mashup Score: 288
Read the full article here
Tweet-
#CRT2025 #JACCINT LBCT: Results of the CRABBIS RCT show that during stepwise provisional stenting in left main or large bifurcations, the PKP ballooning sequence is associated with better stent configuration compared to the PSP https://t.co/4DgSdzn3iO @BURZOTTA_F @LCappannoli https://t.co/lgOoQS0d90
-
-
Mashup Score: 106Clinical Effect of Genetic Testing in Inherited Cardiovascular Diseases: A 14-Year Retrospective Study - 2 day(s) ago
Read the full article here
Tweet-
🧬 24% of patients with heritable arrhythmias & cardiomyopathies carry a disease-causing variant—but only 8% see changes in clinical management. How do we close the gap? Read the study: https://t.co/AhDq8BbqFR #JACC #Genetics #CardioScience #PrecisionMedicine #cvGenetics https://t.co/cVEyLyTJ4u
-
-
Mashup Score: 62Impact of Transcatheter or Surgical Aortic Valve Performance on 5-Year Outcomes in Patients at ≥ Intermediate Risk: - 2 day(s) ago
Read the full article here
Tweet-
#CRT2025 #JACC SimPub: 5-year valve performance is significantly better after CoreValve/Evolut #TAVI compared to surgery. The development of BVD in TAVI and surgery patients was associated with worsened 5-year clinical outcomes. https://t.co/QAX6Rnh6EY #cvSurg https://t.co/drskqNlfQb
-
-
Mashup Score: 206Association Between Cigarette Smoking and Subclinical Markers of Cardiovascular Harm: - 2 day(s) ago
Read the full article here
Tweet-
🚬 Still smoking? Your heart is paying the price. A massive study of 22 cohorts confirms smoking intensity & pack-years drive inflammation, thrombosis, & CV harm. The good news? Quitting reverses damage. https://t.co/eSnUuJ7woz #JACC #SmokingCessation #HeartHealth #ASCVD https://t.co/AQNX4xE3iw
-
-
Mashup Score: 96
Read the full article here
Tweet-
First @ACCinTouch Concise Clinical Guidance (CCG) streamlines processes for implementing best practices in patient care. This CCG focuses on evaluating & managing #cardiogenicshock, answering 🔑 clinical questions & providing actionable guidance. https://t.co/ZOKfMIeuji #JACC https://t.co/Od45CtQM2L
-
B-cell depletion finally delivers on the promise in lupus nephritis. This is a phase three trial of obinutuzumab, type II anti-CD20 monoclonal antibody. It worked.